112 related articles for article (PubMed ID: 10769052)
1. Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues.
Kotera J; Fujishige K; Omori K
J Histochem Cytochem; 2000 May; 48(5):685-93. PubMed ID: 10769052
[TBL] [Abstract][Full Text] [Related]
2. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain.
Giordano D; De Stefano ME; Citro G; Modica A; Giorgi M
Biochim Biophys Acta; 2001 May; 1539(1-2):16-27. PubMed ID: 11389965
[TBL] [Abstract][Full Text] [Related]
3. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
[TBL] [Abstract][Full Text] [Related]
4. Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase.
Liu L; Underwood T; Li H; Pamukcu R; Thompson WJ
Cell Signal; 2002 Jan; 14(1):45-51. PubMed ID: 11747988
[TBL] [Abstract][Full Text] [Related]
5. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
Ni XP; Safai M; Gardner DG; Humphreys MH
Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of bovine type 5 phosphodiesterase confers a renal phenotype in Drosophila.
Broderick KE; Kean L; Dow JA; Pyne NJ; Davies SA
J Biol Chem; 2004 Feb; 279(9):8159-68. PubMed ID: 14662775
[TBL] [Abstract][Full Text] [Related]
7. Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity.
Turko IV; Francis SH; Corbin JD
Biochemistry; 1998 Mar; 37(12):4200-5. PubMed ID: 9521742
[TBL] [Abstract][Full Text] [Related]
8. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.
Mullershausen F; Russwurm M; Koesling D; Friebe A
Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
10. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
Rybalkin SD; Rybalkina IG; Shimizu-Albergine M; Tang XB; Beavo JA
EMBO J; 2003 Feb; 22(3):469-78. PubMed ID: 12554648
[TBL] [Abstract][Full Text] [Related]
11. Expression and regulation of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) in human colonic epithelial cells: role in the induction of cellular refractoriness to the heat-stable enterotoxin peptide.
Bakre MM; Sopory S; Visweswariah SS
J Cell Biochem; 2000 Feb; 77(1):159-67. PubMed ID: 10679826
[TBL] [Abstract][Full Text] [Related]
12. Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat.
Ni XP; Safai M; Rishi R; Baylis C; Humphreys MH
J Am Soc Nephrol; 2004 May; 15(5):1254-60. PubMed ID: 15100365
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5).
Stacey P; Rulten S; Dapling A; Phillips SC
Biochem Biophys Res Commun; 1998 Jun; 247(2):249-54. PubMed ID: 9642111
[TBL] [Abstract][Full Text] [Related]
14. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
15. Expression, distribution and regulation of phosphodiesterase 5.
Lin CS; Lin G; Xin ZC; Lue TF
Curr Pharm Des; 2006; 12(27):3439-57. PubMed ID: 17017938
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
Zhu B; Vemavarapu L; Thompson WJ; Strada SJ
J Cell Biochem; 2005 Feb; 94(2):336-50. PubMed ID: 15526282
[TBL] [Abstract][Full Text] [Related]
17. Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5.
Sopory S; Balaji S; Srinivasan N; Visweswariah SS
FEBS Lett; 2003 Mar; 539(1-3):161-6. PubMed ID: 12650945
[TBL] [Abstract][Full Text] [Related]
18. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters.
Lin CS; Chow S; Lau A; Tu R; Lue TF
Int J Impot Res; 2002 Feb; 14(1):15-24. PubMed ID: 11896473
[TBL] [Abstract][Full Text] [Related]
19. Allosteric activation of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) by cGMP.
Okada D; Asakawa S
Biochemistry; 2002 Jul; 41(30):9672-9. PubMed ID: 12135389
[TBL] [Abstract][Full Text] [Related]
20. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
